Hemiplegia, Physical Disability, Rehabilitation; Tobacco Use, Stroke
Conditions
Brief summary
The goal of this clinical trial is to compare in describeparticipant population. The main question it aims to answer is:By using intelligent portable isokinetic tester and traditional isokinetic tester, isokinetic knee flexor and extensor muscles of stroke patients with hemiplegia were trained respectively, so as to observe and compare the effects of the two treatment methods. In addition, the therapeutic effect of the above two treatments was compared with that of exercise therapy alone. Participants will be divided into three groups: control group, intelligent isokinetic treatment group, and traditional isokinetic treatment group. Participants of both the control group and the two treatment groups received exercise therapy. On the basis of exercise therapy, participants of the intelligent isokinetic treatment group used the intelligent portable isokinetic tester to train the affected knee flexion and extensor muscle, while the participants of traditional isokinetic treatment group used the intelligent portable isokinetic tester to train the affected knee flexion and extensor muscle.
Interventions
DEVICEIntelligent portable isokinetic muscle strength test training
The isokinetic training of knee flexors and extensors was carried out by using intelligent portable isokinetic muscle strength test training system
DEVICEisokinetic muscle strength test training
The isokinetic training of knee flexors and extensors was carried out by using isokinetic muscle strength test training system
OTHERwithout test training
Treatment was performed without using any isokinetic muscle strength test training system
Sponsors
Ran Shi
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)
Eligibility
Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Clinical diagnosis of Cerebral apoplexy's Disease * Confirmed by CT or MR Examination of the head * First onset, duration ≤1 month * The lower extremity of the hemiplegic limb was above Brunnstrom stage III * Must be able to sign the informed consent form
Exclusion criteria
* Vital signs are unstable * Severe cognitive, visual and hearing impairment * Orthopaedic disease * Muscle pain lower extremity * Congenital disease * History of other encephalopathy * History of mental illness
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Body function | up to 1 month | Evaluate lower limb motor function using the Fugl Meyer method (total lower limb motor score 0-34 points, total balance score 0-14 points). |
| Measured peak moment | up to 1 month | Peak moment of knee joint at 60 °/s angular velocity in Nm |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Satisfaction questionnaire survey | up to 1 month | Survey of patients' comfort and satisfaction with the treatment process and effectiveness(score 0-100 points). |
Countries
China
Contacts
Primary ContactRan Shi, doctor
Backup ContactMay Zheng, doctor
Outcome results
None listed